Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
U.S. Physical Therapy (USPH) PT Raised to $103 at Cantor Fitzgerald
-
Tivity Health (TVTY) PT Lowered to $49 at Cantor Fitzgerald
-
Mazor Robotics (MZOR) PT Lowered to $55 at Cantor Fitzgerald
-
Allscripts (MDRX) PT Lowered to $17 at Cantor Fitzgerald
-
Computer Programs and Systems (CPSI) PT Lowered to $28 at Cantor Fitzgerald
-
MSCI Inc. (MSCI) PT Raised to $192 at Cantor Fitzgerald
-
Global Payments (GPN) PT Raised to $136 at Cantor Fitzgerald
-
CytoSorbents Achieves Record Total Revenue and CytoSorb Sales in the Second Quarter 2018
-
Teladoc (TDOC) PT Raised to $52 at Cantor Fitzgerald Following 2Q
-
Health Insurance Innovations (HIIQ) PT Raised to $65 at Cantor Fitzgerald
-
Cross Country Healthcare (CCRN) PT Lowered to $10 at Cantor Fitzgerald
-
Verisk Analytics (VRSK) PT Raised to $130 at Cantor Fitzgerald
-
TherapeuticsMD (TXMD) Prices Combined $65M Common Share Offering and $20M Registered Direct Offering by Investor at $5.10/Sh
-
TherapeuticsMD Announces Pricing of Its Underwritten Public Offering and Concurrent Registered Direct Offering for Aggregate Gross Proceeds of $85 Million
-
AxoGen, Inc. Reports 2018 Second Quarter Financial Results
-
AxoGen, Inc. Reports 2018 Second Quarter Financial Results
-
Humana (HUM) PT Raised to $295 at Cantor Fitzgerald
-
WellCare Health Plans (WCG) PT Raised to $292 at Cantor Fitzgerald
-
Fidelity National Information Services (FIS) PT Raised to $117 at Cantor Fitzgerald
-
Fiserv (FISV) PT Raised to $73 at Cantor Fitzgerald
-
TherapeuticsMD (TXMD) Announces $65M Underwritten Public Offering and Concurrent $20M Registered Direct Offering
-
TherapeuticsMD Announces Proposed $65 Million Underwritten Public Offering and Concurrent $20 Million Registered Direct Offering of Common Stock
-
WellCare Health Plans (WCG) PT Raised to $292 at Cantor Fitzgerald
-
Reata Pharmaceuticals, Inc. Announces Closing of Class A Common Stock Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
UPDATE: Cantor Fitzgerald Starts uniQure BV (QURE) at Overweight
-
Orchid Island Capital Announces Second Quarter 2018 Results
-
Intermex Completes Merger with FinTech Acquisition Corp. II
-
Intermex Completes Merger with FinTech Acquisition Corp. II
-
Stryker (SYK) PT Raised to $175 at Cantor Fitzgerald
-
Insurer Anthem profit beats estimates on lower patient costs
-
Reata Pharma (RETA) Prices 3M Class A Share Common Offering at $72/Sh
-
Reata Pharmaceuticals, Inc. Announces Pricing of Class A Common Stock Public Offering
-
Horizon Pharma (HZNP) PT Raised to $21 at Cantor Fitzgerald
-
Syntel, Inc. (SYNT) PT Raised to $41 at Cantor Fitzgerald
-
Monroe Capital Sponsors Thunder Bridge Acquisition, Ltd.
-
Reata Pharma (RETA) Announces 3M Share Proposed Public Offering of Class A Common Stock
-
Reata Pharmaceuticals, Inc. Announces Proposed Public Offering of Class A Common Stock
-
Cantor Fitzgerald Starts Kindred Biosciences (KIN) at Buy
-
Endo International plc (ENDP) PT Raised to $12 at Cantor Fitzgerald
-
Timothy Swift Leaves Cantor Fitzgerald to Join Viking Energy Group as Executive V.P. & COO
-
Timothy Swift Leaves Cantor Fitzgerald to Join Viking Energy Group as Executive V.P. & COO
-
FinTech Acquisition Corp. II Stockholders Approve Definitive Merger Agreement with Intermex Holdings II, Inc.
-
LifePoint Health (LPNT) Buyout Could Boost Hospitals Valuations - Cantor Fitzgerald
-
Exponent (EXPO) PT Raised to $56 at Cantor Fitzgerald
-
Zynerba Pharma (ZYNE) Prices 4.06M Offering of Common Stock at $8/Sh
-
Zynerba Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Cerus (CERS) PT Raised to $9 at Cantor Fitzgerald Following Investor Meetings
-
Intuitive Surgical (ISRG) Has Plenty of Room To Run - Cantor Fitzgerald
-
Zynerba Pharma (ZYNE) Announces Proposed Common Share Offering
-
Zynerba Pharmaceuticals (ZYNE) Plans Public Offering of Common Stock

